The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn BPC 157: Experimental Peptide Creates Risk for Athletes Research Peptides In Minnesota: Why Not For Human Consumption Doesn't Protect You Holt Law When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Is BPC157 Legal? WADA, FDA Status, and What You Need to Know